Kailera Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $16-$28.23 |
Market Cap | $2.6B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.78 |
News
See moreYahoo Finance • 8 days ago
Kardigan rises in Nasdaq debut after upsized $400 million IPO
Yahoo Finance • 12 days ago
Notable healthcare headlines for the week: GSK, Parabilis Medicines, and Novo Nordisk in focus
Yahoo Finance • last month
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
Yahoo Finance • last month
This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst
About
CEO | Mr. Ronald C. Renaud Jr., M.B.A. |
Address | 180 Third Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 145 |